Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Solid Biosciences (SLDB) Return on Equity (2018 - 2024)

Solid Biosciences (SLDB) has disclosed Return on Equity for 7 consecutive years, with 0.57% as the latest value for Q3 2024.

  • Quarterly Return on Equity rose 14.0% to 0.57% in Q3 2024 from the year-ago period, while the trailing twelve-month figure was 0.57% through Sep 2024, up 14.0% year-over-year, with the annual reading at 0.57% for FY2023, 8.0% down from the prior year.
  • Return on Equity hit 0.57% in Q3 2024 for Solid Biosciences, down from 0.45% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.32% in Q2 2021 to a low of 3.14% in Q3 2020.
  • Historically, Return on Equity has averaged 0.83% across 5 years, with a median of 0.57% in 2024.
  • Biggest five-year swings in Return on Equity: tumbled -198bps in 2020 and later skyrocketed 282bps in 2021.
  • Year by year, Return on Equity stood at 1.14% in 2020, then skyrocketed by 71bps to 0.33% in 2021, then crashed by -75bps to 0.59% in 2022, then dropped by -23bps to 0.72% in 2023, then rose by 20bps to 0.57% in 2024.
  • Business Quant data shows Return on Equity for SLDB at 0.57% in Q3 2024, 0.45% in Q2 2024, and 0.54% in Q1 2024.